Invention Grant
- Patent Title: Urinary triaosylceramide (Gb3) as a marker of cardiac disease
-
Application No.: US14729630Application Date: 2015-06-03
-
Publication No.: US09750732B2Publication Date: 2017-09-05
- Inventor: Raphael Schiffmann , Fanny Mochel , Lawrence Sweetman , Sabrina Forni
- Applicant: Baylor Research Institute
- Agency: Servilla Whitney LLC
- Main IPC: A61K31/445
- IPC: A61K31/445 ; A61B10/00 ; G01N30/88
Abstract:
The present invention describes a method for determination of urinary globotriaosylceramide (Gb3) levels in non-Fabry disease cardiac patients. Determination of Gb3 levels provides a screening method for determining cardiac risk and may offer an alternative therapeutic option for cardiac disease management or cardiac disease risk mitigation by lowering Gb3 levels by the use of pharmacological chaperones or other agents.
Public/Granted literature
- US20150342939A1 Urinary Triaosylceramide (GB3) as a Marker of Cardiac Disease Public/Granted day:2015-12-03
Information query
IPC分类:
